Tag Archives: prognosis
December 2024 Br J Cardiol 2024;31:144–9 doi:10.5837/bjc.2024.053
Evaluating real-world mortality risk after defibrillator implantation
Lisa W M Leung, Zaki Akhtar, Oswaldo Valencia, Genevieve Shouls, Rabia Warraich, Jennifer Vara, Sue Jones, Pamala Kanagasabapathy, Mark M Gallagher, Nesan Shanmugam
Introduction There is a wide range of cardiac conditions that may significantly increase the risk of sudden cardiac death (SCD). They range from ischaemic heart disease to inherited cardiac conditions, such as hypertrophic obstructive cardiomyopathy, and these may be in the setting of primary or secondary prevention. Potential device candidates are expected to have a reasonable life-expectancy of at least one year.1 While clear guidelines help cardiologists and their multi-disciplinary teams to steer the right patients forward for a defibrillator device and to the right type, it is recognised that it may be difficult to assess the frailty of
June 2024 Br J Cardiol 2024;31:80 doi:10.5837/bjc.2024.024
Emergency pacemaker implantation in nonagenarians with CHB: single- versus dual-chamber pacing
Edd Maclean, Karishma Mahtani, Maurizio Parker, Rohan Vyas, Roy Bo Wang, Marina Roelas, Nikhil Ahluwalia, Vijayabharathy Kanthasamy, Antonio Creta, Malcolm Finlay, Ross J Hunter, Syed Ahsan, Mark J Earley, Pier D Lambiase, James Elliott, Filip Zemrak, Amal Muthumala, Philip Moore, Simon Sporton, Anthony Chow, Christopher Monkhouse
Introduction In ambulatory individuals with high-grade atrioventricular (AV) block, it is well-established that restoration of AV synchrony with dual-chamber pacing confers important physiological benefits over single-chamber pacing, including improvements in exercise capacity, reduction in incident atrial fibrillation (AF), and avoidance of pacemaker (PPM) syndrome.1,2 The impact of dual-chamber pacing on mortality remains disputed and, in older people, it has been proposed that the expected advantages of physiological pacing strategies may be mitigated by the higher prevalence of comorbidities and non-arrhythmic death.1,3 Accordingly, the
November 2007 Br J Cardiol 2007;14:275-79
Improving access to financial support for heart failure patients: understanding the claims process and the doctors’ role
Christopher Ward
Easily accessible routine clinical data are summarised that identify patients whose claims are most likely to succeed. Introduction Dr Christopher Ward The financial difficulties of the NHS, including those of cardiac services, are often highlighted in the medical press. However, patients’ financial problems are rarely addressed and the specific issue of helping heart failure patients to obtain their financial entitlements has never been discussed in the Journals. It is now widely accepted that patients with heart failure have similar needs for supportive and palliative care as do patients with cancer: to control physical and psychologica
May 2005 Br J Cardiol 2005;12:205-8
Heart failure after myocardial infarction: a neglected problem?
Martin R Cowie, Larry Lacey, Maggie Tabberer
No content available
November 2004 Br J Cardiol (Acute Interv Cardiol) 2004;11:AIC 89–AIC 92
An investigation into the prognostic value of the cardiac marker troponin T in patients with suspected acute coronary syndrome without ST segment elevation
Aidan Kirkpatrick, Michael Martin, Philip Lewis, Simon Capewell, Gary Cook, Georgios Lyratzopoulos
No content available
June 2002 Br J Cardiol 2002;9:313-6
Left ventricular hypertrophy: a target for treatment
Jamil Mayet, Rebecca Lane
No content available
February 2002 Br J Cardiol 2002;9:103-5
Prognosis, outcome and recurrence of stroke
Graham Venables
No content available
For healthcare professionals only
